| Primary |
| Hyperthyroidism |
52.1% |
| Basedow's Disease |
35.2% |
| Nasopharyngitis |
1.9% |
| Drug Use For Unknown Indication |
1.4% |
| Hypothyroidism |
1.4% |
| Thyroid Disorder |
1.4% |
| Anxiety |
0.5% |
| Atrial Fibrillation |
0.5% |
| Blood Pressure Increased |
0.5% |
| Goitre |
0.5% |
| Graves' Disease |
0.5% |
| Haemoptysis |
0.5% |
| Hepatitis C |
0.5% |
| Hypertension |
0.5% |
| Prostate Cancer |
0.5% |
| Rash |
0.5% |
| Thyroiditis |
0.5% |
| Thyrotoxicosis |
0.5% |
| Thyroxine Increased |
0.5% |
| Urinary Tract Infection |
0.5% |
|
| Jaundice Cholestatic |
15.7% |
| Agranulocytosis |
7.2% |
| Rash |
7.2% |
| Pyrexia |
6.0% |
| Foetal Exposure During Pregnancy |
4.8% |
| Pancreatitis Acute |
4.8% |
| Twin Pregnancy |
4.8% |
| Urticaria |
4.8% |
| Vitello-intestinal Duct Remnant |
4.8% |
| Ageusia |
3.6% |
| Dysmorphism |
3.6% |
| Hypothyroidism |
3.6% |
| Joint Effusion |
3.6% |
| Maternal Drugs Affecting Foetus |
3.6% |
| Myalgia |
3.6% |
| Pruritus |
3.6% |
| Systemic Lupus Erythematosus |
3.6% |
| Thirst |
3.6% |
| Vomiting |
3.6% |
| White Blood Cell Count Decreased |
3.6% |
|
| Secondary |
| Hyperthyroidism |
18.4% |
| Hypertension |
13.3% |
| Product Used For Unknown Indication |
13.3% |
| Breast Cancer |
10.7% |
| Basedow's Disease |
7.2% |
| Diabetes Mellitus |
5.5% |
| Atrial Fibrillation |
4.0% |
| Hiv Infection |
3.5% |
| Blood Pressure |
2.9% |
| Hepatitis C |
2.9% |
| Bipolar I Disorder |
2.3% |
| Anticoagulant Therapy |
2.0% |
| Thrombosis Prophylaxis |
2.0% |
| Thyroid Disorder |
2.0% |
| Arthralgia |
1.7% |
| Drug Use For Unknown Indication |
1.7% |
| Hypercholesterolaemia |
1.7% |
| Mania |
1.7% |
| Toxic Nodular Goitre |
1.7% |
| Cardiac Failure Congestive |
1.4% |
|
| Pancytopenia |
10.7% |
| Cutaneous Vasculitis |
7.1% |
| Stevens-johnson Syndrome |
7.1% |
| Acute Generalised Exanthematous Pustulosis |
5.4% |
| Chest Discomfort |
5.4% |
| Drug Hypersensitivity |
5.4% |
| Pancreatitis Acute |
5.4% |
| Platelet Count Decreased |
5.4% |
| Prothrombin Level Increased |
5.4% |
| Weight Decreased |
5.4% |
| Wound Secretion |
5.4% |
| Adverse Event |
3.6% |
| Blood Urine Present |
3.6% |
| Drug Ineffective |
3.6% |
| Goitre Congenital |
3.6% |
| Haematoma |
3.6% |
| Hepatocellular Injury |
3.6% |
| International Normalised Ratio Increased |
3.6% |
| Lung Neoplasm Malignant |
3.6% |
| Neuroleptic Malignant Syndrome |
3.6% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.5% |
| Hyperthyroidism |
11.7% |
| Drug Use For Unknown Indication |
10.4% |
| Hypertension |
10.1% |
| Atrial Fibrillation |
5.2% |
| Rheumatoid Arthritis |
4.4% |
| Pain |
3.7% |
| Chronic Obstructive Pulmonary Disease |
3.6% |
| Thyroid Disorder |
3.1% |
| Prophylaxis |
2.9% |
| Diabetes Mellitus |
2.6% |
| Blood Cholesterol Increased |
2.5% |
| Osteoporosis |
2.5% |
| Anxiety |
2.3% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Headache |
2.1% |
| Basedow's Disease |
1.9% |
| Multiple Myeloma |
1.9% |
| Pulmonary Arterial Hypertension |
1.8% |
| Contraception |
1.7% |
|
| Hyperthyroidism |
7.8% |
| Hypothyroidism |
7.8% |
| Vision Blurred |
6.7% |
| Nausea |
5.7% |
| Dyspnoea |
5.2% |
| Rash |
5.2% |
| Thrombocytopenia |
5.2% |
| Thyroid Disorder |
5.2% |
| Vomiting |
5.2% |
| Weight Decreased |
5.2% |
| Death |
4.7% |
| Headache |
4.7% |
| Weight Increased |
4.7% |
| Pyrexia |
4.1% |
| Throat Irritation |
4.1% |
| Toxic Nodular Goitre |
4.1% |
| Pneumonia |
3.6% |
| Sepsis |
3.6% |
| Tremor |
3.6% |
| White Blood Cell Count Increased |
3.6% |
|
| Interacting |
| Erectile Dysfunction |
33.3% |
| Thyroid Disorder |
33.3% |
| Atrial Fibrillation |
16.7% |
| Basedow's Disease |
16.7% |
|
| Drug Interaction |
66.7% |
| International Normalised Ratio Fluctuation |
33.3% |
|
